Centrexion Therapeutics is a clinical-stage biopharmaceutical company developing a broad pipeline of novel, non-opioid, non-addictive therapies for chronic pain and immunology. Its mechanism-driven approach spans topical, injectable, and oral modalities, with partnerships with Lilly, Boehringer Ingelheim, Sanofi, and NIH validating its scientific platform. The company aims to be the premier pain therapeutics powerhouse by addressing safety and efficacy gaps in current treatments.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2024
Jun 2023
Oct 2020
Jan 2018
Dec 2016
Jan 2013
Jan 2013
Create a free account to see which investors have funded this company.
Create Free Account
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
